Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.59, No.4, p.469-474, 2012 |
||
Title: Melatonin enhanced bexarotene efficacy in experimental mammary carcinogenesis | ||
Author: P. ORENDAS, P. KUBATKA, K. KAJO, N. STOLLAROVA, M. KASSAYOVA, B. BOJKOVA, M. PEC, V. NOSAL, T. KISKOVA, K. ZIHLAVNIKOVA, R. KARSNAKOVA | ||
Abstract: The aim of this paper was to test lower, safe bexarotene dose administered alone and in combination with melatonin to improve its efficacy. Mammary carcinogenesis was induced by N-methyl-N-nitrosourea in female Sprague-Dawley rats, administered in two doses intraperitoneally between 42.-54. postnatal days and chemoprevention was initiated 7 days prior to first N-methyl-N-nitrosourea injection and lasted 15 weeks. Bexarotene, particularly in combination with melatonin decreased mammary tumor incidence and frequency with a shift from poorly to well differentiated carcinomas. Bexarotene alleviated glycaemia and liver/heart muscle glycogen concentration decreased as well as liver/thymus malondialdehyde increased in comparison with control group. The combination of bexarotene and melatonin is therefore beneficial in preventive-curative model of experimental mammary carcinogenesis and may be applied in oncological practice as such. |
||
Keywords: mammary carcinogenesis, female rats, bexarotene, melatonin, prevention | ||
Published online: 10-Apr-2012 | ||
Year: 2012, Volume: 59, Issue: 4 | Page From: 469, Page To: 474 | |
doi:10.4149/neo_2012_060 |
||
|
download file |
|